Initial Testing of Topotecan by the Pediatric Preclinical Testing Program

BACKGROUND: Topotecan is a small molecule DNA topoisomerase I poison, that has been successful in clinical trials against pediatric solid tumors and leukemias. Topotecan was evaluated against the PPTP tumor panels as part of a validation process for these preclinical models. PROCEDURES: In vivo thre...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Carol, Hernan, Houghton, Peter J., Morton, Christopher L., Kolb, E. Anders, Gorlick, Richard, Reynolds, C. Patrick, Kang, Min H., Maris, John M., Keir, Stephen T., Watkins, Amy, Smith, Malcolm A., Lock, Richard B.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2010
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2923808/
https://ncbi.nlm.nih.gov/pubmed/20017204
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.22352
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky